Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nurses and clinical trials

S L Snyder1

  • 1Southwest Cardiovascular Research, Tucson, Arizona.

The Journal of Cardiovascular Nursing
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

This article details the U.S. Food and Drug Administration (FDA) clinical trial process for new products. It highlights the essential, often unlimited, roles nurses play and discusses current regulatory challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Site-specific regulation of CA(V)2.2 channels by protein kinase C isozymes betaII and epsilon.

Neuroscience·2009
Same author

Characterization of the yeast tricalbins: membrane-bound multi-C2-domain proteins that form complexes involved in membrane trafficking.

Cellular and molecular life sciences : CMLS·2004
Same author

The copines, a novel class of C2 domain-containing, calcium-dependent, phospholipid-binding proteins conserved from Paramecium to humans.

The Journal of biological chemistry·1998
Same author

A survey estimate of academic liver transplant teams' selection practices for alcohol-dependent applicants.

Psychosomatics·1996
Same author

Identification, localization, and functional implications of an abundant nematode annexin.

The Journal of cell biology·1996
Same author

Identification of the major chromaffin granule-binding protein, chromobindin A, as the cytosolic chaperonin CCT (chaperonin containing TCP-1).

The Journal of biological chemistry·1994
Same journal

Predictors of Prolonged Intensive Care Unit Stay After Heart Valve Surgery: A Case-Control Study.

The Journal of cardiovascular nursing·2026
Same journal

Characteristics and Care Practices in People Hospitalized for Heart Failure With Coexisting Diabetes: A Single-Center Retrospective Observational Study.

The Journal of cardiovascular nursing·2026
Same journal

Association of a Diet Index for the Gut Microbiome With Hypertension and Obesity-Related Hypertension: A Cross-Sectional Analysis of NHANES 2007-2020.

The Journal of cardiovascular nursing·2026
Same journal

Device-Assessed Physical Activity and Cardiometabolic Health in Chinese American Women With a History of Gestational Diabetes Mellitus.

The Journal of cardiovascular nursing·2026
Same journal

Physical Frailty, Self-Care Behaviors, and 6-Month Clinical Outcomes Among Adults With Heart Failure.

The Journal of cardiovascular nursing·2026
Same journal

Challenges Experienced by Patients With Chronic Venous Disease in Unresolved Postoperative Recovery After Iliac Vein Stenting: A Phenomenological Study.

The Journal of cardiovascular nursing·2026
See all related articles

Area of Science:

  • Regulatory Science
  • Clinical Research Nursing

Background:

  • The Food and Drug Administration (FDA) oversees the clinical trial process for new product approvals in the United States.
  • Nurses play a critical role in the execution and oversight of clinical trials.

Purpose of the Study:

  • To explore the FDA's clinical trial process for new products.
  • To delineate the extensive roles nurses fulfill within this process.
  • To discuss contemporary regulatory issues impacting nurses in clinical trials.

Main Methods:

  • Literature review of FDA guidelines and regulations.
  • Analysis of nursing responsibilities in clinical trial settings.
  • Examination of recent regulatory case studies and discussions.

Related Experiment Videos

Main Results:

  • The FDA clinical trial process involves multiple complex stages.
  • Nurses provide a wide range of essential services, often exceeding defined roles.
  • Regulatory challenges exist concerning the scope of practice and patient advocacy for nurses.

Conclusions:

  • Understanding the FDA process is crucial for effective clinical trial participation.
  • The multifaceted contributions of nurses are vital to trial integrity and patient safety.
  • Addressing regulatory ambiguities will enhance nursing roles in clinical research.